Bartlett's Medical Management of HIV Infection

THE PIONEERING WORK IN HIV MEDICINE, COMPLETELY REVISED FOR THE FIRST TIME SINCE 2012

The 17th edition of Bartlett's Medical Management of HIV Infection offers the best-available clinical guidance for treatment of patients with HIV. Edited by preeminent and pioneering authorities in HIV research and clinical care, it has earned its status as the definitive work for physicians, physician assistants, nurse practitioners, pharmacists, and anyone working in the care of persons with HIV.

Updated to reflect the most recent innovations in HIV prevention and therapy, this text balances new and old approaches to produce a guide to clinical management in any setting. Coverage includes:

· New approaches to prevention of HIV and prevention of infection in patients with HIV
· Laboratory protocols for screening and treatment
· Antiretroviral therapies (including dosage and adverse effects and drug interactions )
· HIV treatment in resource-limited settings
· Management of infections

A portable, navigable guide to an exquisitely complex field, Bartlett's Medical Management of HIV Infection is the continuing standard for practice and education in the field of HIV.

John G. Bartlett, MD, is Professor Emeritus at the Johns Hopkins University School of Medicine. An internationally renowned authority on AIDS and other infectious diseases, he has co-chaired the U.S. Department of Health and Human Services' panel on antiretroviral agents since its inception in 1996. Across 26 years at Johns Hopkins, he led worldwide efforts to understand, prevent, and treat AIDS. He is the author of more than 500 articles, 280 book chapters, and 60 editions of 18 books. He has served on editorial boards for 19 medical journals.

Robert R. Redfield, MD, is a pioneer in clinical human viral research, with notable accomplishments in the area of HIV immunoregulation, immunotherapy, and vaccine development. In collaboration with Dr. Robert Gallo's group in the mid-1980's, Redfield was the first to demonstrate heterosexual transmission of HIV-1. Today his research focuses on applying research strategies to bring treatment to millions of people living with HIV infection particularly in resource-limited parts of the world. He is former Professor of Medicine, Microbiology, and Immunology, Director of Clinical Care and Research, and Chief of Infectious Diseases at the University of Maryland's Institute of Human Virology.

Paul A. Pham, PharmD, is Managing Partner of Westview Urgent Care MediCenter in Frederick, Maryland, and Adjunct Instructor of Medicine at Johns Hopkins University School of Medicine. His primary interests include HIV/AIDS clinical care, infectious disease pharmacology, and antiretroviral drug interactions. Pham has more than 20 years of clinical experience in the inpatient care of AIDS and general infectious disease services; he has also served as principal investigator for antiretroviral drug interaction studies. He is a committee member of the CDC/NIH/IDSA opportunistic infection guidelines and the HIV Assist point-of-care program.